Sjögren's disease: open trials in Brazil

4 open trials have a site in Brazil. Registry data; only the trial team decides who can take part.

NCT06991114
AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
Trial Treatment · Phase 2 · Artiva Biotherapeutics, Inc.
Artiva Investigational Site Brasília, Brasília · Artiva Investigational Site Cuiabá, Cuiabá · Artiva Investigational Site Porto Alegre, Porto Alegre · Artiva Investigational Site Rio Grande, Rio Grande · Artiva Investigational Site Sao Paulo, São Paulo
Registry updated 2026-07-31
NCT07371468
A Study of GSK5926371 in Participants With B-cell Driven Autoimmune Rheumatic Diseases (ARD)
Trial Treatment · Phase 1 · GlaxoSmithKline
Campinas · São Paulo
Registry updated 2026-06-23
NCT06747949
A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)
Trial Treatment · Phase 3 · Amgen
Centro de Estudos em Terapias Inovadoras, Curitiba · LMK Servicos Medicos SS, Porto Alegre · SER - Serviços Especializados em Reumatologia da Bahia S/S - ME, Salvador
Registry updated 2026-04-28
NCT07153276
TREATMENT OF VAGINAL DRYNESS IN SJÖGREN'S DISEASE WITH CO2-LASER VERSUS TOPICAL PROMESTRIENE
Trial Treatment · Phase 4 · University of Sao Paulo General Hospital
University of São Paulo General Hospital, São Paulo
Registry updated 2026-03-03

This page is not medical advice. Talk to your doctor before contacting a trial.

AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.